Sonoma Pharmaceuticals (SNOA) Institutional Ownership $2.63 +0.08 (+3.14%) (As of 12/20/2024 05:23 PM ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Sonoma Pharmaceuticals (NASDAQ:SNOA)CurrentInstitutional OwnershipPercentage1.95%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$31.93KNumber ofInstitutional Sellers(last 12 months)0 Get SNOA Insider Trade Alerts Want to know when executives and insiders are buying or selling Sonoma Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SNOA Institutional Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Sonoma Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/29/2024 Ground Swell Capital LLC10,400$32K0.0%N/A1.083% 11/16/2021 Squarepoint Ops LLC15,712$88K0.0%N/A0.751% 8/13/2021 Renaissance Technologies LLC92,167$677K0.0%-6.7%4.406% 8/13/2021 Geode Capital Management LLC30,181$221K0.0%N/A1.443% 8/13/2021 Vanguard Group Inc.27,975$205K0.0%+44.9%1.337% 5/13/2021 Renaissance Technologies LLC98,826$734K0.0%+7.7%4.758% 5/11/2021 Acadian Asset Management LLC6,026$45K0.0%-29.5%0.290% 2/10/2021 Renaissance Technologies LLC91,734$666K0.0%-3.2%4.421% (Data available from 1/1/2016 forward) SNOA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SNOA shares? During the previous two years, the following institutional investors and hedge funds held shares of Sonoma Pharmaceuticals shares: Ground Swell Capital LLC ($32K).Learn more on SNOA's institutional investors. What percentage of Sonoma Pharmaceuticals stock is owned by institutional investors? 1.95% of Sonoma Pharmaceuticals stock is owned by institutional investors. Learn more on SNOA's institutional investor holdings. Which institutional investors have been buying Sonoma Pharmaceuticals stock? The following institutional investors have purchased Sonoma Pharmaceuticals stock in the last 24 months: Ground Swell Capital LLC ($10.40K). How much institutional buying is happening at Sonoma Pharmaceuticals? Institutional investors have bought a total of 10,400 shares in the last 24 months. This purchase volume represents approximately $31.93K in transactions. Related Companies Cara Therapeutics Institutional Ownership Acurx Pharmaceuticals Institutional Ownership Marinus Pharmaceuticals Institutional Ownership TherapeuticsMD Institutional Ownership HCW Biologics Institutional Ownership AIM ImmunoTech Institutional Ownership PharmaCyte Biotech Institutional Ownership Sol-Gel Technologies Institutional Ownership Aspira Women's Health Institutional Ownership ImmunoPrecise Antibodies Institutional Ownership This page (NASDAQ:SNOA) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonoma Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sonoma Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SNOA Stock Alerts